P135 Has treatment with EPO+/-G-CSF an impact on progression to AML and survival in low/int-1-risk MDS? A comparison between French-EPO patients and the IMRAW database
Titel:
P135 Has treatment with EPO+/-G-CSF an impact on progression to AML and survival in low/int-1-risk MDS? A comparison between French-EPO patients and the IMRAW database
Auteur:
Park, S. Grabar, S. Kelaidi, C. Beyne-Rauzy, O. Picard, F. Vassilieff, D. Coiteux, V. Leroux, G. Lepelley, P. Dombret, H. Daniel, M.T. Cheze, S. Mahé, B. Adés, L. Ferrant, A. Ravoet, C. Vey, N. Escoffre-Barbe, M. Aljassem, L. Bourgeois, K. Greenberg, P. Fenaux, P. Dreyfus, F.